TT
Healthcare & Life Sciences
Tactiva Therapeutics
United States
Tactiva Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Tactiva Therapeutics
Tactiva Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Tactiva Therapeutics develops next-generation adaptive cell therapies using a T-cell receptor approach that combines CD4 and CD8 systems, with a lead autologous DEACT program targeting NY-ESO-1 in ovarian and other solid tumors, which has received IND clearance in the US.
Explore Tactiva Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.